{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:54:02Z","timestamp":1794779642113,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["214187"],"award-info":[{"award-number":["214187"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["01789"],"award-info":[{"award-number":["01789"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.atherosclerosis.2025.119158","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:56:30Z","timestamp":1740743790000},"page":"119158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice"],"prefix":"10.1016","volume":"403","author":[{"given":"Karolina","family":"Lindberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ovchinnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-651X","authenticated-orcid":false,"given":"Matthias B.","family":"Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pirault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel FJ.","family":"Ketelhuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-9201","authenticated-orcid":false,"given":"Hannes","family":"Olauson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran K.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias E.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119158_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119158_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.119158_bib3","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fendo.2018.00351","article-title":"FGF23 in cardiovascular disease: innocent bystander or active mediator?","volume":"9","author":"St\u00f6hr","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.119158_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003486","article-title":"Plasma fibroblast growth factor 23: clinical correlates and association with cardiovascular disease and mortality in the framingham heart study","volume":"5","author":"Haring","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119158_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00240-022-01317-2","article-title":"Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers","volume":"50","author":"Moor","year":"2022","journal-title":"Urolithiasis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119158_bib7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119158_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011925","article-title":"Fibroblast growth factor 23 and long-term cardiac function: the multi-ethnic study of atherosclerosis","volume":"13","author":"Patel","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119158_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119158_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/heartjnl-2016-309764","article-title":"Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip","volume":"103","author":"Lind","year":"2017","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119158_bib11","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.119158_bib12","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119158_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123817","article-title":"Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD","volume":"4","author":"Clinkenbeard","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119158_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New insights into the FGF23-Klotho axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119158_bib15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119158_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/14712598.3.6.911","article-title":"Hydrodynamic delivery of DNA","volume":"3","author":"Hodges","year":"2003","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.119158_bib17","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-beta signaling in T cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119158_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2353\/ajpath.2009.080561","article-title":"T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-\/-) mice","volume":"174","author":"Ovchinnikova","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119158_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119158_bib20","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cvr\/cvac161","article-title":"Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis","volume":"119","author":"Zernecke","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119158_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99518-z","article-title":"Association between phosphate and long-term outcome in CAD patients underwent coronary intervention","volume":"11","author":"Tsai","year":"2021","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.119158_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145693","article-title":"Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression","volume":"131","author":"Shiizaki","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119158_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000515622","article-title":"Aldosterone and mineralocorticoid receptor signaling as determinants of cardiovascular and renal injury: from hans selye to the present","volume":"52","author":"Epstein","year":"2021","journal-title":"Am. J. Nephrol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2025.119158_bib24","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms20174195","article-title":"The role of fibroblast growth factor 23 in inflammation and anemia","volume":"20","author":"Czaya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119158_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119158_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95488-4","article-title":"Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease","volume":"11","author":"Donate-Correa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5171945","article-title":"The biological role of Klotho protein in the development of cardiovascular diseases","volume":"2018","author":"Olejnik","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000467479.89943.a3","article-title":"4A.05: circulating FGF-23 as an independent correlate of hypertension and atherosclerosis in early stages of CKD","volume":"33","author":"Dimas","year":"2015","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119158_bib29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","article-title":"Chemokines in atherosclerosis: proceedings resumed","volume":"34","author":"Zernecke","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119158_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/cells10040951","article-title":"Targeting inflammatory pathways in cardiovascular disease: the inflammasome, interleukin-1, interleukin-6 and beyond","volume":"10","author":"Libby","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119158_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1248\/bpb.b14-00276","article-title":"Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice","volume":"38","author":"Masuda","year":"2015","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119158_bib32","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.transproceed.2014.09.015","article-title":"FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients","volume":"46","author":"Malyszko","year":"2014","journal-title":"Transplant. Proc."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.119158_bib33","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/01.CIR.0000017265.52501.37","article-title":"Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability","volume":"105","author":"Moreno","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119158_bib34","first-page":"127","article-title":"Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery","volume":"23","author":"Yamashita","year":"2008","journal-title":"Histol. Histopathol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119158_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105739","article-title":"Impact of age-dependent adventitia inflammation on structural alteration of abdominal aorta in hyperlipidemic mice","volume":"9","author":"Sakamoto","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119158_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bone.2008.01.019","article-title":"Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice","volume":"42","author":"Hollberg","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib37","article-title":"The emerging role of Th1 cells in atherosclerosis and its implications for therapy","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119158_bib38","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119158_bib39","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1210\/en.2018-00174","article-title":"Increased circulating FGF23 does not lead to cardiac hypertrophy in the male Hyp mouse model of XLH","volume":"159","author":"Liu","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119158_bib40","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119158_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/gt.2008.141","article-title":"Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition","volume":"16","author":"Bursill","year":"2009","journal-title":"Gene Ther."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.119158_bib42","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","article-title":"Sex as a biological variable in atherosclerosis","volume":"126","author":"Man","year":"2020","journal-title":"Circ. Res."},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2025.119158_bib43","first-page":"49","article-title":"Sex differences in inflammation during atherosclerosis","volume":"8","author":"Fairweather","year":"2014","journal-title":"Clin. Med. Insights Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119158_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(99)00081-7","article-title":"Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice","volume":"145","author":"Caligiuri","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/109275","article-title":"Links between vitamin D deficiency and cardiovascular diseases","volume":"2015","author":"Mozos","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119158_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/8756-3282(95)00420-3","article-title":"Effects of altered diet on serum levels of 1,25-dihydroxyvitamin D and parathyroid hormone in X-linked hypophosphatemic (Hyp and Gy) mice","volume":"18","author":"Meyer","year":"1996","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119158_bib47","doi-asserted-by":"crossref","first-page":"F584","DOI":"10.1152\/ajprenal.00298.2023","article-title":"C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23","volume":"326","author":"Hu","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119158_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nefro.2021.03.001","article-title":"Iron repletion and FGF23 regulation. A potentially dangerous combination","volume":"41","author":"Rodelo-Haad","year":"2021","journal-title":"Nefrologia"},{"key":"10.1016\/j.atherosclerosis.2025.119158_bib49","unstructured":"Higashimoto Y, Tanaka K, Sakaguchi T, Yamagishi S ichi, Motomiya Y. Fibroblast Growth Factor 23 Contributes to Regulation of Hepcidin\/Ferroportin Axis."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:52:12Z","timestamp":1777409532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"alternative-id":["S0021915025000553"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119158","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119158"}}